|
2024 Winter Meeting |
|
Enduring |
|
$0.00 |
|
SGO Journal Club On-Demand: Advanced Endometrial Cancer—the Next Generation of Treatment |
|
Enduring |
|
$0.00 |
|
Palliative Care Module Series - Part 2 (no CE) |
|
Enduring |
|
$0.00 |
|
SGO Taskforce for Board Certification Support Statistic Webinar Series - Part 1 |
|
Enduring |
|
$0.00 |
|
SGO Taskforce for Board Certification Support Statistic Webinar Series - Part 2 |
|
Enduring |
|
$0.00 |
|
SGO Taskforce for Board Certification Support Statistic Webinar Series - Part 3 |
|
Enduring |
|
$0.00 |
|
Ocular Toxicities with ADCs Companion Card |
|
Enduring |
|
$0.00 |
|
SGO Taskforce for Board Certification Support Statistic Webinar Series - Part 4 |
|
Enduring |
|
$0.00 |
|
Treatment Related Cardiotoxicity: Review and Management Companion Card |
|
Enduring |
|
$0.00 |
|
Basics of Gyn Oncology Coding On-Demand Webinar (2024) |
|
Enduring |
|
$0.00 |
|
Highlights from the SGO 2024 Annual Meeting on Women's Cancer |
|
Enduring |
|
$195.00 |
|
Molecular Target: Human Epidermal Growth Factor Receptor 2 (HER2) |
|
Enduring |
|
$0.00 |
|
SGO Late Breaking: 2024 FDA Approvals |
|
Enduring |
|
$0.00 |
|
SGO Late Breaking: SGO 2024 |
|
Enduring |
|
$0.00 |
|
SGO Late Breaking: ASCO 2024 |
|
Enduring |
|
$0.00 |
Facebook
X
LinkedIn
Forward